Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Startups & Unicorns companies in Monoclonal antibody
by Highest Patent Value in the China in 2022

The Monoclonal antibody top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Monoclonal antibody Startups & Unicorns in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.
#
Company Name
Region
Tech Topics
Total
1
Avg patent value: 1.85 M
2
Avg patent value: 542,500
3
Liquid biopsy,Health care
Avg patent value: 230,000
4
Biopharmaceutical,Medicine,Health care,
...[+2]
Avg patent value: 220,000
5
Avg patent value: 180,000
6
Medicine,Health care,Diagnostic Reagent,
...[+2]
Avg patent value: 128,571
7
Health care,Cell,Hematological neoplasm,
...[+2]
Avg patent value: 76,850
8
Hangzhou Sumgen Biotech Co., Ltd.
Avg patent value: 64,000
9
Gene,Biology,Health care,
...[+2]
Avg patent value: 63,000
10
Avg patent value: 47,085
11
Health care,Immunotherapy,Drug
Avg patent value: 18,155
12
Cell therapy,Pharmacy and Therapeutics,Epacadostat,
...[+2]
Avg patent value: 12,300
13
Medical equipment,Medicine,Health care,
...[+2]
Avg patent value: 3,700
14
Avg patent value: 3,600
15
Avg patent value: 3,550
16
Avg patent value: 3,500
17
Hangzhou Biolynx Technology Co. Ltd.
Avg patent value: 3,500
18
Target protein,Health care
Avg patent value: 3,400
19
Avg patent value: 0
20
Cell therapy,Health care
Avg patent value: 0
Page generation time: Jul 18 2025